A determination of the pre-analytical storage conditions for insulin like growth factor-I and type III procollagen peptide
A determination of the pre-analytical storage conditions for insulin like growth factor-I and type III procollagen peptide
OBJECTIVE: IGF-I and type III procollagen (P-III-P) have been proposed as markers to detect GH abuse. This study aims to determine whether the pre-analytical storage temperature or delayed centrifugation affect the measured IGF-I and P-III-P concentrations. DESIGN: Observational study. SETTING: Wellcome Trust Clinical Research Facility, Southampton. SUBJECTS: Nineteen healthy volunteers. INTERVENTION: Blood was collected into bottles containing a clotting agent, lithium heparin or EDTA. One sample from each group was centrifuged and stored at -80 degrees C (control sample). The remaining samples from each group were stored as either serum or whole blood at 4 degrees C or room temperature for up to five days prior to storage at -80 degrees C. OUTCOME MEASURES: IGF-I and P-III-P. RESULTS: The storage temperature or timing of centrifugation did not appear to affect IGF-I concentration. In contrast, the measured P-III-P concentration rose by 6.5-7% per day in clotted and lithium heparin samples when stored as whole blood (p<0.006) or serum (6.2-6.5% per day) at room temperature (p<0.001). P-III-P did not change when the samples were stored at 4 degrees C. Although collection into EDTA inhibited the rise in P-III-P, the baseline measured values were significantly higher than in other media and spiking experiments demonstrated that EDTA exerted a significant matrix effect on the assay. CONCLUSION: While the optimum collection method is immediate centrifugation and storage at -80 degrees C, it would seem acceptable to store serum or clotted blood samples at 4 degrees C, but not ambient temperature, for up to five days. It is incumbent on the anti-doping authorities to provide facilities to allow this
disease, temperature, insulin, metabolism, procollagen, growth, blood, health, adult
43-50
Holt, Richard I.G.
d54202e1-fcf6-4a17-a320-9f32d7024393
Erotokritou-Mulligan, Ioulietta
8bb8720a-eda7-4ad4-b969-0b35c5e5226c
Ridley, Sean A.
36339064-c3b8-4351-a6a1-99011e724e13
McHugh, Cathy M.
53361620-56a3-4a64-8ebf-3a13aa08213a
Bassett, E. Eryl
fefd7f16-2045-4700-adaa-7cc6049933a4
Cowan, David A.
22bdafa8-cee8-481a-97d5-2687fcf325ca
Bartlett, Christiaan
ed9cba27-96ef-419e-824b-fabab5c7cba8
Sonksen, Peter H.
b3cf05ef-65c2-4e9b-8d95-b7c3aaf532cd
February 2009
Holt, Richard I.G.
d54202e1-fcf6-4a17-a320-9f32d7024393
Erotokritou-Mulligan, Ioulietta
8bb8720a-eda7-4ad4-b969-0b35c5e5226c
Ridley, Sean A.
36339064-c3b8-4351-a6a1-99011e724e13
McHugh, Cathy M.
53361620-56a3-4a64-8ebf-3a13aa08213a
Bassett, E. Eryl
fefd7f16-2045-4700-adaa-7cc6049933a4
Cowan, David A.
22bdafa8-cee8-481a-97d5-2687fcf325ca
Bartlett, Christiaan
ed9cba27-96ef-419e-824b-fabab5c7cba8
Sonksen, Peter H.
b3cf05ef-65c2-4e9b-8d95-b7c3aaf532cd
Holt, Richard I.G., Erotokritou-Mulligan, Ioulietta, Ridley, Sean A., McHugh, Cathy M., Bassett, E. Eryl, Cowan, David A., Bartlett, Christiaan and Sonksen, Peter H.
(2009)
A determination of the pre-analytical storage conditions for insulin like growth factor-I and type III procollagen peptide.
Growth Hormone & IGF Research, 19 (1), .
(doi:10.1016/j.ghir.2008.06.001).
Abstract
OBJECTIVE: IGF-I and type III procollagen (P-III-P) have been proposed as markers to detect GH abuse. This study aims to determine whether the pre-analytical storage temperature or delayed centrifugation affect the measured IGF-I and P-III-P concentrations. DESIGN: Observational study. SETTING: Wellcome Trust Clinical Research Facility, Southampton. SUBJECTS: Nineteen healthy volunteers. INTERVENTION: Blood was collected into bottles containing a clotting agent, lithium heparin or EDTA. One sample from each group was centrifuged and stored at -80 degrees C (control sample). The remaining samples from each group were stored as either serum or whole blood at 4 degrees C or room temperature for up to five days prior to storage at -80 degrees C. OUTCOME MEASURES: IGF-I and P-III-P. RESULTS: The storage temperature or timing of centrifugation did not appear to affect IGF-I concentration. In contrast, the measured P-III-P concentration rose by 6.5-7% per day in clotted and lithium heparin samples when stored as whole blood (p<0.006) or serum (6.2-6.5% per day) at room temperature (p<0.001). P-III-P did not change when the samples were stored at 4 degrees C. Although collection into EDTA inhibited the rise in P-III-P, the baseline measured values were significantly higher than in other media and spiking experiments demonstrated that EDTA exerted a significant matrix effect on the assay. CONCLUSION: While the optimum collection method is immediate centrifugation and storage at -80 degrees C, it would seem acceptable to store serum or clotted blood samples at 4 degrees C, but not ambient temperature, for up to five days. It is incumbent on the anti-doping authorities to provide facilities to allow this
This record has no associated files available for download.
More information
Published date: February 2009
Keywords:
disease, temperature, insulin, metabolism, procollagen, growth, blood, health, adult
Identifiers
Local EPrints ID: 70424
URI: http://eprints.soton.ac.uk/id/eprint/70424
PURE UUID: 6cdf0e9b-a0e0-4a59-8362-fba7630d90a5
Catalogue record
Date deposited: 10 Feb 2010
Last modified: 14 Mar 2024 02:45
Export record
Altmetrics
Contributors
Author:
Ioulietta Erotokritou-Mulligan
Author:
Sean A. Ridley
Author:
Cathy M. McHugh
Author:
E. Eryl Bassett
Author:
David A. Cowan
Author:
Christiaan Bartlett
Author:
Peter H. Sonksen
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics